111 related articles for article (PubMed ID: 24502136)
1. [Oligomeric state investigation of flavocytochrome CYP102A1 using AFM with standard and supersharp probes].
Ivanov IuD; Bukharina NS; Frantsuzov PA; Krokhin NV; Kanashenko SL; Archakov AI
Biomed Khim; 2013; 59(4):378-87. PubMed ID: 24502136
[TBL] [Abstract][Full Text] [Related]
2. [Atomic force microscopy visualization and measurement of the activity and physicochemical properties of single monomeric and oligomeric enzymes].
Ivanov IuD; Bukharina NS; Pleshakova TO; Frantsuzov PA; Krokhin NV; Ziborov VS; Archakov AI
Biofizika; 2011; 56(5):939-44. PubMed ID: 22117449
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Monomeric and Dimeric Structures of CYP102A1 Using AlphaFold2 and AlphaFold Multimer and Assessment of Point Mutation Effect on the Efficiency of Intra- and Interprotein Electron Transfer.
Ivanov YD; Taldaev A; Lisitsa AV; Ponomarenko EA; Archakov AI
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209175
[TBL] [Abstract][Full Text] [Related]
4. Mapping protein-protein interactions in homodimeric CYP102A1 by crosslinking and mass spectrometry.
Felker D; Zhang H; Bo Z; Lau M; Morishima Y; Schnell S; Osawa Y
Biophys Chem; 2021 Jul; 274():106590. PubMed ID: 33894563
[TBL] [Abstract][Full Text] [Related]
5. The effect of mutation of F87 on the properties of CYP102A1-CYP4C7 chimeras: altered regiospecificity and substrate selectivity.
Chen CK; Shokhireva TKh; Berry RE; Zhang H; Walker FA
J Biol Inorg Chem; 2008 Jun; 13(5):813-24. PubMed ID: 18392864
[TBL] [Abstract][Full Text] [Related]
6. A highly active single-mutation variant of P450BM3 (CYP102A1).
Whitehouse CJ; Bell SG; Yang W; Yorke JA; Blanford CF; Strong AJ; Morse EJ; Bartlam M; Rao Z; Wong LL
Chembiochem; 2009 Jul; 10(10):1654-6. PubMed ID: 19492389
[TBL] [Abstract][Full Text] [Related]
7. AFM study of membrane proteins, cytochrome P450 2B4, and NADPH-cytochrome P450 reductase and their complex formation.
Kiselyova OI; Yaminsky IV; Ivanov YD; Kanaeva IP; Kuznetsov VY; Archakov AI
Arch Biochem Biophys; 1999 Nov; 371(1):1-7. PubMed ID: 10525282
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of monomeric reconstituted and membrane microsomal monooxygenase systems of the rabbit liver. I. Properties of NADPH-cytochrome P450 reductase and cytochrome P450 LM2 (2B4) monomers.
Kanaeva IP; Dedinskii IR; Skotselyas ED; Krainev AG; Guleva IV; Sevryukova IF; Koen YM; Kuznetsova GP; Bachmanova GI; Archakov AI
Arch Biochem Biophys; 1992 Nov; 298(2):395-402. PubMed ID: 1416970
[TBL] [Abstract][Full Text] [Related]
9. Crystals in Minutes: Instant On-Site Microcrystallisation of Various Flavours of the CYP102A1 (P450BM3) Haem Domain.
Stanfield JK; Omura K; Matsumoto A; Kasai C; Sugimoto H; Shiro Y; Watanabe Y; Shoji O
Angew Chem Int Ed Engl; 2020 May; 59(19):7611-7618. PubMed ID: 32157795
[TBL] [Abstract][Full Text] [Related]
10. An efficient route to selective bio-oxidation catalysts: an iterative approach comprising modeling, diversification, and screening, based on CYP102A1.
Seifert A; Antonovici M; Hauer B; Pleiss J
Chembiochem; 2011 Jun; 12(9):1346-51. PubMed ID: 21591046
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of 4-hexylbenzoic acid and 4-nonyloxybenzoic acid as substrates of CYP102A1.
Gudiminchi RK; Smit MS
Appl Microbiol Biotechnol; 2011 Apr; 90(1):117-26. PubMed ID: 21161210
[TBL] [Abstract][Full Text] [Related]
12. Evolved CYP102A1 (P450BM3) variants oxidise a range of non-natural substrates and offer new selectivity options.
Whitehouse CJ; Bell SG; Tufton HG; Kenny RJ; Ogilvie LC; Wong LL
Chem Commun (Camb); 2008 Feb; (8):966-8. PubMed ID: 18283351
[TBL] [Abstract][Full Text] [Related]
13. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
[TBL] [Abstract][Full Text] [Related]
14. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
15. Reduction of dioxygen catalyzed by pyrene-wired heme domain cytochrome P450 BM3 electrodes.
Udit AK; Hill MG; Bittner VG; Arnold FH; Gray HB
J Am Chem Soc; 2004 Aug; 126(33):10218-9. PubMed ID: 15315414
[TBL] [Abstract][Full Text] [Related]
16. Structure, electronic properties and catalytic behaviour of an activity-enhancing CYP102A1 (P450(BM3)) variant.
Whitehouse CJ; Yang W; Yorke JA; Tufton HG; Ogilvie LC; Bell SG; Zhou W; Bartlam M; Rao Z; Wong LL
Dalton Trans; 2011 Oct; 40(40):10383-96. PubMed ID: 21603690
[TBL] [Abstract][Full Text] [Related]
17. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
18. Investigating the applicability of the CYP102A1-decoy-molecule system to other members of the CYP102A subfamily.
Stanfield JK; Onoda H; Ariyasu S; Kasai C; Burfoot EM; Sugimoto H; Shoji O
J Inorg Biochem; 2023 Aug; 245():112235. PubMed ID: 37167731
[TBL] [Abstract][Full Text] [Related]
19. [Electrochemical measurement of intraprorein and interprotein electron transfer].
Shumiantseva VV; Bulko TV; Lisitsina VB; Urlakher VB; Kuzikov AB; Suprun EV; Archakov AI
Biofizika; 2013; 58(3):453-60. PubMed ID: 24159813
[TBL] [Abstract][Full Text] [Related]
20. A role for the strained phenylalanine ring rotation induced by substrate binding to cytochrome CYP102A1.
Haines DC
Protein Pept Lett; 2006; 13(10):977-80. PubMed ID: 17168818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
